Colgate-Palmolive’s premium strategy and pet nutrition expansion drive growth, with a $115 target signaling 26% upside. Read more about CL stock here.

BNY Mellon Small Cap Growth Fund outperformed its benchmark, the Russell 2000 Growth Index during Q4 2024. Click here to read ...

Primoris (PRIM) announced that David King, Chairman and prior CEO, has been named Interim President and CEO. David will succeed Tom McCormick, ...

While modern society’s relationship with mental health as evolved in recent decades, pharmaceutical innovation has yet to keep pace, mostly due ...